Abstract: A method, a system and an apparatus for wastewater treatment using a combination of separation of fat, oil and grease (FOG) and biological treatment for reducing the amount of fat, oil and grease (FOG) in wastewater with the aid of a liquid culture of microorganisms is provided. In particular, the technology disclosed relates to a method and process for the separation and treatment of FOG, as well as a container tank and an outlet pipe construction adapted for improving the gravimetric FOG separation process and the breaking down of FOG using microorganisms.

Abstract: A method, a system and an apparatus for wastewater treatment using a combination of separation of fat, oil and grease (FOG) and biological treatment for reducing the amount of fat, oil and grease (FOG) in wastewater with the aid of a liquid culture of microorganisms is provided. In particular, the technology disclosed relates to a method and process for the separation and treatment of FOG, as well as a container tank and an outlet pipe construction adapted for improving the gravimetric FOG separation process and the breaking down of FOG using microorganisms.

Abstract: A method for displaying an image in an electronic device provided. The method includes displaying an image and if a filter effect list request is input, dividing at least a portion of the image into a plurality of filter areas, and displaying a preview image in which different filter effects are applied to the plurality of filter areas.

Abstract: A method for displaying an image in an electronic device provided. The method includes displaying an image and if a filter effect list request is input, dividing at least a portion of the image into a plurality of filter areas, and displaying a preview image in which different filter effects are applied to the plurality of filter areas.

Abstract: The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9? have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, artherosclerosis and acromegaly. A preferred compound is picropodophyllin.

Abstract: A disposal device for collecting bags for bodily fluids has a receptacle for receiving at least one collecting bag containing bodily fluid, a comminution unit (2) for comminuting the collecting bag, a fluid collecting basin (5) for receiving the bodily fluid, a particle collecting container (8) for receiving the comminuted collecting bag, and at least one decontamination unit (7) for the decontamination of the collecting bag and the bodily fluid.

Abstract: There is disclosed use of certain picro derivatives of cyclolignans for prophylaxis or treatment of diseases or conditions characterised by a hyperactive immune system. Examples of cyclolignans according to the invention include picropodophyllin, deoxypicropodophyllin, anhydropicropodophyllol or deoxyanhydropicropodophyllol.

Abstract: Manufacturing of miniaturised three-dimensional electric components are presented, as well as components manufactured by the methods. The manufacturing methods comprise micro-replication of at least one master structure, e.g. via a mould structure, in at least one polymer layer onto which layer at least one conductive path is provided.

Abstract: There is disclosed use of certain cyclolignans for prophylaxis or treatment of diabetes mellitus type 2, nephropathy, retinopathy, macular degeneration, retinopathy of prematurity, central retinal vein occlusion, branch retinal vein occlusion, rubeotic glaucoma, thyroid eye disease, corneal graft rejection and corneal chemical burns; and for contraception. Preferred compounds are picropodophyllin, deoxypicropodophyllin and anhydropicropodophyllol. There is also described a method of treatment of an eye disease.

Abstract: The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9? have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, artherosclerosis and acromegaly. A preferred compound is picropodophyllin.

Abstract: Compounds which inhibit the insulin-like growth factor-1 receptor (IGF-1 R) and methods for using them for treating IGF-1 R dependent diseases, such as cancer.

Abstract: The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9? have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, atherosclerosis and acromegaly. A preferred compound is picropodophyllin.

Abstract: A disposal device for collecting bags for bodily fluids has a receptacle for receiving at least one collecting bag containing bodily fluid, a comminution unit (2) for comminuting the collecting bag, a fluid collecting basin (5) for receiving the bodily fluid, a particle collecting container (8) for receiving the comminuted collecting bag, and at least one decontamination unit (7) for the decontamination of the collecting bag and the bodily fluid.

Abstract: The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9? have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, artherosclerosis and acromegaly. A preferred compound is picropodophyllin.

Abstract: The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9? have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, artherosclerosis and acromegaly. A preferred compound is picropodophyllin.

Abstract: The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9? have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, atherosclerosis and acromegaly. A preferred compound is picropodophyllin.

Abstract: The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9? have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, artherosclerosis and acromegaly. A preferred compound is picropodophyllin.

Abstract: The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9? have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, artherosclerosis and acromegaly. A preferred compound is picropodophyllin.

Abstract: Manufacturing of miniaturised three-dimensional electric components are presented, as well as components manufactured by the methods. The manufacturing methods comprise micro-replication of at least one master structure, e.g. via a mould structure, in at least one polymer layer onto which layer at least one conductive path is provided.

Abstract: Manufacturing of miniaturized three-dimensional electric components are presented, as well as components manufactured by the methods. The manufacturing methods comprise micro-replication of at least one master structure, e.g. via a mould structure, in at least one polymer layer onto which layer at least one conductive path is provided.